PTEN and melanoma: In melanoma, the loss of PTEN (tumor suppressor that negatively regulates AKT/PI3K activity) leads to decreased numbers of TILs, reduced responsiveness to PD-1 checkpoint inhibition, and increased secretion of immunosuppressive cytokines [62].